Coalition urges Congress to repeal medical device tax
September 26, 2019
— The ADA and more than 600 stakeholders are asking lawmakers to permanently repeal the medical device tax
set to take effect at the end of 2019.
The medical device tax is a 2.3% tax on the sale of most medical devices sold in the U.S., including dental restorative materials, instruments, impression materials and equipment. The tax was twice suspended by Congress and the most recent suspension will expire Jan. 1, 2020.
In previous advocacy efforts, the ADA has told legislators
the dental device manufacturing industry estimates the tax could increase the cost of dental care by more than $160 million annually. The ADA has also noted that operating costs for dental practices, particularly specialties, are significant, and the ability to sustain or grow small businesses such as dental practices could be further strained with the implementation of the medical device tax.
“We respectfully request that Congress prioritize repeal of the medical device tax before it causes any more harm to the innovation ecosystem,” the groups wrote.
Follow all of the ADA’s advocacy efforts at ADA.org/advocacy